Correlation Between CVS Health and Sanara Medtech

Can any of the company-specific risk be diversified away by investing in both CVS Health and Sanara Medtech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CVS Health and Sanara Medtech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CVS Health Corp and Sanara Medtech, you can compare the effects of market volatilities on CVS Health and Sanara Medtech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CVS Health with a short position of Sanara Medtech. Check out your portfolio center. Please also check ongoing floating volatility patterns of CVS Health and Sanara Medtech.

Diversification Opportunities for CVS Health and Sanara Medtech

0.47

Correlation Coefficient

CVS Health  Sanara Medtech

Very weak diversification

The 3 months correlation between CVS and Sanara is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding CVS Health Corp and Sanara Medtech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sanara Medtech and CVS Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CVS Health Corp are associated (or correlated) with Sanara Medtech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sanara Medtech has no effect on the direction of CVS Health i.e., CVS Health and Sanara Medtech go up and down completely randomly.

Pair Corralation between CVS Health and Sanara Medtech

Considering the 90-day investment horizon CVS Health Corp is expected to under-perform the Sanara Medtech. But the stock apears to be less risky and, when comparing its historical volatility, CVS Health Corp is 1.31 times less risky than Sanara Medtech. The stock trades about 0.0 of its potential returns per unit of risk. The Sanara Medtech is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  3,650  in Sanara Medtech on December 4, 2024 and sell it today you would lose (368.00) from holding Sanara Medtech or give up 10.08% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

CVS Health Corp  vs.  Sanara Medtech

CVS Health Corp

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in CVS Health Corp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, CVS Health unveiled solid returns over the last few months and may actually be approaching a breakup point.

Sanara Medtech

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sanara Medtech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Pair Trading with CVS Health and Sanara Medtech

The main advantage of trading using opposite CVS Health and Sanara Medtech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CVS Health position performs unexpectedly, Sanara Medtech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sanara Medtech will offset losses from the drop in Sanara Medtech's long position.

The idea behind CVS Health Corp and Sanara Medtech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.